<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:51:48Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9939071" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9939071</identifier>
        <datestamp>2023-02-20</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jah38102" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9939071</article-id>
              <article-id pub-id-type="pmcid">PMC9939071</article-id>
              <article-id pub-id-type="pmc-uid">9939071</article-id>
              <article-id pub-id-type="pmid">36628985</article-id>
              <article-id pub-id-type="pmid">36628985</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.122.026684</article-id>
              <article-id pub-id-type="publisher-id">JAH38102</article-id>
              <article-id pub-id-type="other">JAHA/2022/026684</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Preventive Cardiology</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the <styled-content style="fixed-case" toggle="no">DASH‐Sodium</styled-content> Trial</article-title>
                <alt-title alt-title-type="right-running-head"><styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet and Time Course of Cardiac Biomarkers</alt-title>
                <alt-title alt-title-type="left-running-head">Belanger et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah38102-cr-0001" contrib-type="author">
                  <name>
                    <surname>Belanger</surname>
                    <given-names>Matthew J.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1988-6289</contrib-id>
                  <xref rid="jah38102-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0002" contrib-type="author">
                  <name>
                    <surname>Kovell</surname>
                    <given-names>Lara C.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7919-2361</contrib-id>
                  <xref rid="jah38102-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0003" contrib-type="author">
                  <name>
                    <surname>Turkson‐Ocran</surname>
                    <given-names>Ruth‐Alma</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9932-052X</contrib-id>
                  <xref rid="jah38102-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0004" contrib-type="author">
                  <name>
                    <surname>Mukamal</surname>
                    <given-names>Kenneth J.</given-names>
                  </name>
                  <degrees>MD, MPH</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8450-6970</contrib-id>
                  <xref rid="jah38102-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0005" contrib-type="author">
                  <name>
                    <surname>Liu</surname>
                    <given-names>Xiaoran</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7356-645X</contrib-id>
                  <xref rid="jah38102-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0006" contrib-type="author">
                  <name>
                    <surname>Appel</surname>
                    <given-names>Lawrence J.</given-names>
                  </name>
                  <degrees>MD, MPH</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0673-6823</contrib-id>
                  <xref rid="jah38102-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0007" contrib-type="author">
                  <name>
                    <surname>Miller</surname>
                    <given-names>Edgar R.</given-names>
                    <suffix>III</suffix>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0157-6258</contrib-id>
                  <xref rid="jah38102-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0008" contrib-type="author">
                  <name>
                    <surname>Sacks</surname>
                    <given-names>Frank M.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1341-1995</contrib-id>
                  <xref rid="jah38102-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0009" contrib-type="author">
                  <name>
                    <surname>Christenson</surname>
                    <given-names>Robert H.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2612-9083</contrib-id>
                  <xref rid="jah38102-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0010" contrib-type="author">
                  <name>
                    <surname>Rebuck</surname>
                    <given-names>Heather</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref rid="jah38102-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0011" contrib-type="author">
                  <name>
                    <surname>Chang</surname>
                    <given-names>Alex R.</given-names>
                  </name>
                  <degrees>MD, MHS</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8114-7447</contrib-id>
                  <xref rid="jah38102-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jah38102-cr-0012" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Juraschek</surname>
                    <given-names>Stephen P.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4168-2696</contrib-id>
                  <xref rid="jah38102-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <address>
                    <email>sjurasch@bidmc.harvard.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="jah38102-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology, Department of Medicine</named-content>
                <institution>Johns Hopkins Medical Institutions</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38102-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology</named-content>
                <institution>University of Massachusetts Chan Medical School</institution>
                <city>Worcester</city>
                <named-content content-type="country-part">MA</named-content>
              </aff>
              <aff id="jah38102-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Beth Israel Deaconess Medical Center</named-content>
                <institution>Harvard Medical School</institution>
                <city>Boston</city>
                <named-content content-type="country-part">MA</named-content>
              </aff>
              <aff id="jah38102-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Harvard T.H. Chan School of Public Health, Harvard Medical School</named-content>
                <institution>Brigham and Women’s Hospital</institution>
                <city>Boston</city>
                <named-content content-type="country-part">MA</named-content>
              </aff>
              <aff id="jah38102-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">The Johns Hopkins University School of Medicine</named-content>
                <institution>The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38102-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Department of Pathology</named-content>
                <institution>University of Maryland School of Medicine</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38102-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <institution>Geisinger Health</institution>
                <city>Danville</city>
                <named-content content-type="country-part">PA</named-content>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>Correspondence to: Stephen P. Juraschek, MD, PhD, Section for Research, Division of General Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave, CO‐1309, room 216, Boston, MA 02215. Email: <email>sjurasch@bidmc.harvard.edu</email>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>11</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>17</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="160">2</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.v12.2</issue-id>
              <elocation-id>e026684</elocation-id>
              <history>
                <date date-type="received">
                  <day>07</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>23</day>
                  <month>11</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--Copyright &#x000a9; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JAH3-12-e026684.pdf"/>
              <abstract>
                <sec id="jah38102-sec-0001">
                  <title>Background</title>
                  <p>The Dietary Approaches to Stop Hypertension (DASH) diet has been shown to reduce biomarkers of cardiovascular disease. We aimed to characterize the time course of change in biomarkers of cardiac injury (high‐sensitivity cardiac troponin I), cardiac strain (NT‐proBNP [N‐terminal pro‐B‐type natriuretic peptide]), and inflammation (hs‐CRP [high‐sensitivity C‐reactive protein]) while consuming the DASH diet.</p>
                </sec>
                <sec id="jah38102-sec-0002">
                  <title>Methods and Results</title>
                  <p>The DASH‐Sodium trial was a randomized controlled trial of 412 adults with elevated blood pressure or hypertension. Participants were randomly assigned to 12 weeks of the DASH diet or a typical American diet. Energy intake was adjusted to maintain body weight. Measurements of high‐sensitivity cardiac troponin I, NT‐proBNP, and hs‐CRP were performed in stored serum specimens, collected at baseline and ≈4, 8, and 12 weeks after randomization. In both the control diet and DASH diet, levels of NT‐proBNP decreased; however, there was no difference between diets (<italic toggle="no">P</italic>‐trend compared with control=0.22). On the DASH diet versus control, levels of high‐sensitivity cardiac troponin I decreased progressively during follow‐up (<italic toggle="no">P‐</italic>trend compared with control=0.025), but a statistically significant between‐diet difference in change from baseline levels was not observed until week 12 (% difference, 17.78% [95% CI, −29.51% to −4.09%]). A similar pattern was evident for hs‐CRP (<italic toggle="no">P‐</italic>trend compared with control=0.01; % difference at week 12, 19.97% [95% CI, −31.94% to −5.89%]).</p>
                </sec>
                <sec id="jah38102-sec-0003">
                  <title>Conclusions</title>
                  <p>In comparison with a typical American diet, the DASH diet reduced high‐sensitivity cardiac troponin I and hs‐CRP progressively over 12 weeks. These results suggest that the DASH diet has cumulative benefits over time on biomarkers of subclinical cardiac injury and inflammation.</p>
                </sec>
                <sec id="jah38102-sec-0004">
                  <title>Registration</title>
                  <p>URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>; Unique identifier: NCT00000608.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah38102-kwd-0001">biomarkers</kwd>
                <kwd id="jah38102-kwd-0002">Dietary Approaches to Stop Hypertension diet</kwd>
                <kwd id="jah38102-kwd-0003">hs‐CRP (high‐sensitivity C‐reactive protein)</kwd>
                <kwd id="jah38102-kwd-0004">high‐sensitivity troponin</kwd>
                <kwd id="jah38102-kwd-0005">NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide)</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Cardiovascular Disease</kwd>
                <kwd>Diet and Nutrition</kwd>
                <kwd>Primary Prevention</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Heart, Lung, and Blood Institute
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K23HL135273</award-id>
                  <award-id>RR00722</award-id>
                  <award-id>RR02635</award-id>
                  <award-id>HL02642</award-id>
                  <award-id>HL50982</award-id>
                  <award-id>HL50977</award-id>
                  <award-id>HL50972</award-id>
                  <award-id>HL50968</award-id>
                  <award-id>HL50981</award-id>
                  <award-id>R21HL144876</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>Office of Research on Minority Health</funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Center for Research Resources
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000097</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="3"/>
                <page-count count="17"/>
                <word-count count="6168"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>17 January 2023</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:24.01.2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="jah38102-ntgp-0001">
                <fn id="jah38102-note-0001">
                  <p>Presented in part at the American Heart Association EPI|Lifestyle Scientific Sessions 2022 in Chicago, IL, March 1 to 4, 2022, and published in abstract form (<italic toggle="yes">Circulation</italic>. 2022;145:A047 or <ext-link xlink:href="https://doi.org/10.1161/circ.145.suppl_1.047" ext-link-type="uri">https://doi.org/10.1161/circ.145.suppl_1.047</ext-link>).</p>
                </fn>
                <fn id="jah38102-note-0002">
                  <p>Supplemental Material is available at <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.026684" ext-link-type="uri">https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.026684</ext-link>
</p>
                </fn>
                <fn id="jah38102-note-0003">
                  <p>For Sources of Funding and Disclosures, see page 9.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jah38102-body-0001">
            <def-list list-content="abbreviations" id="jah38102-lp-0001">
              <title>Nonstandard Abbreviations and Acronyms</title>
              <def-item>
                <term id="jah38102-li-0001">DASH</term>
                <def id="jah38102-li-0002">
                  <p>Dietary Approaches to Stop Hypertension</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38102-li-0003">hs‐cTnI</term>
                <def id="jah38102-li-0004">
                  <p>high‐sensitivity cardiac troponin I</p>
                </def>
              </def-item>
            </def-list>
            <p>
              <boxed-text position="anchor" content-type="box" id="jah38102-blkfxd-0001">
                <caption>
                  <title>Clinical Perspective</title>
                </caption>
                <sec id="jah38102-sec-0008">
                  <title>What Is New?</title>
                  <p>
                    <list list-type="bullet" id="jah38102-list-0001">
                      <list-item id="jah38102-li-0005">
                        <p>In this secondary analysis of the DASH (Dietary Approaches to Stop Hypertension)–Sodium trial, the magnitude of the DASH diet's effects on high‐sensitivity cardiac troponin I and hs‐CRP (high‐sensitivity C‐reactive protein) increased over time.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
                <sec id="jah38102-sec-0009">
                  <title>What Are the Clinical Implications?</title>
                  <p>
                    <list list-type="bullet" id="jah38102-list-0002">
                      <list-item id="jah38102-li-0006">
                        <p>The DASH diet has cumulative benefits over time on biomarkers of subclinical cardiac injury and systemic inflammation.</p>
                      </list-item>
                      <list-item id="jah38102-li-0007">
                        <p>Knowledge of the time course of change in biomarkers of cardiovascular disease is informative when counseling patients on the expected benefits of the DASH diet.</p>
                      </list-item>
                      <list-item id="jah38102-li-0008">
                        <p>Innovative strategies that support sustained adherence to the DASH diet are needed to improve population cardiovascular health.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </boxed-text>
            </p>
            <p>Cardiovascular disease (CVD) is the leading cause of death in the United States.<xref rid="jah38102-bib-0001" ref-type="bibr"><sup>1</sup></xref> Most deaths from CVD can be attributed to specific modifiable risk factors,<xref rid="jah38102-bib-0002" ref-type="bibr"><sup>2</sup></xref> with suboptimal diet being a leading risk factor for disability and death in the United States.<xref rid="jah38102-bib-0003" ref-type="bibr"><sup>3</sup></xref> The Dietary Approaches to Stop Hypertension (DASH) diet, rich in fruits, vegetables, and low‐fat dairy and reduced in saturated fat and cholesterol,<xref rid="jah38102-bib-0004" ref-type="bibr"><sup>4</sup></xref> is associated with a lower risk of CVD events over time<xref rid="jah38102-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jah38102-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38102-bib-0007" ref-type="bibr"><sup>7</sup></xref> and has been promoted by the American Heart Association to improve population cardiovascular health.<xref rid="jah38102-bib-0008" ref-type="bibr"><sup>8</sup></xref>
</p>
            <p>Although the beneficial effects of the DASH diet on traditional cardiovascular risk factors (ie, blood pressure and lipids) have been established,<xref rid="jah38102-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="jah38102-bib-0009" ref-type="bibr"><sup>9</sup></xref> we recently demonstrated that the DASH diet improves biomarkers of subclinical cardiac injury (high‐sensitivity cardiac troponin I [hs‐cTnI]) and inflammation (hs‐CRP [high‐sensitivity C‐reactive protein]) but not a biomarker of cardiac strain (NT‐proBNP [N‐terminal pro‐B‐type natriuretic peptide]) during a 12‐week feeding period.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref> However, our prior work did not address how soon these changes might be observed after the adoption of the DASH diet or whether they are sustained over time. Understanding the pattern of change is important as the duration of lifestyle change needed to see an effect is not known, and some have questioned whether the impact of diet on subclinical injury is temporary.</p>
            <p>In this secondary analysis of the DASH‐Sodium trial, we examined the time course of change in biomarkers of cardiac injury, strain, and inflammation (hs‐cTnI, NT‐proBNP, and hs‐CRP) from consuming the DASH diet in comparison with a typical American diet using measurements obtained at baseline and at approximately weeks 4, 8, and 12 after randomization. We hypothesized the following: (1) changes in hs‐cTnI and hs‐CRP from the DASH diet would be observed as early as 4 weeks and sustained over the 12‐week study period; and (2) there would be no difference in changes in NT‐proBNP between diets at any of the measured time points.</p>
            <sec sec-type="methods" id="jah38102-sec-0010">
              <title>METHODS</title>
              <p>Deidentified data from the DASH‐Sodium trial are available through the National Heart, Lung, and Blood Institute Biological Specimen and Data Repository Information Coordinating Center.</p>
              <p>The DASH‐Sodium trial was an investigator‐initiated trial funded by the National Heart, Lung, and Blood Institute, conducted at 4 clinical centers (Baltimore, MD; Boston, MA; Durham, NC; and Baton Rouge, LA) from September 1997 through November 1999.<xref rid="jah38102-bib-0009" ref-type="bibr"><sup>9</sup></xref> Details of the study rationale, design, and protocol have been reported previously.<xref rid="jah38102-bib-0009" ref-type="bibr"><sup>9</sup></xref>, <xref rid="jah38102-bib-0011" ref-type="bibr"><sup>11</sup></xref> In brief, the DASH‐Sodium trial examined 2 dietary strategies to lower blood pressure: the DASH diet and a control diet typical of nutrient intakes in the United States. These diets were tested at 3 different levels of sodium consumption. The study protocol was approved by the institutional review boards at each respective study center. Participants provided written, informed consent for participation in the trial and the use of their stored biospecimens in subsequent analyses. The measurement of biomarkers in stored specimens curated by the Biological Specimen and Data Repository Information Coordinating Center in the present study was supported by the National Heart, Lung, and Blood Institute and was determined to be exempt research by the Beth Israel Deaconess Medical Center Institutional Review Board. The DASH‐Sodium trial is registered at <ext-link xlink:href="http://clinicaltrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link>, identifier: NCT00000608.</p>
              <sec id="jah38102-sec-0011">
                <title>Participants</title>
                <p>The DASH‐Sodium trial recruited adult men and women, aged ≥22 years, with a mean systolic blood pressure of 120 to 159 mm Hg and a mean diastolic blood pressure of 80 to 95 mm Hg. Adults with a history of heart disease, including symptomatic ischemic heart disease, myocardial infarction, coronary artery bypass grafting, angioplasty, congestive heart failure, or stroke, were excluded.<xref rid="jah38102-bib-0009" ref-type="bibr"><sup>9</sup></xref> Other criteria for exclusion were renal insufficiency, poorly controlled hyperlipidemia, diabetes, the use of antihypertensive medications or insulin, or intake of &gt;14 alcoholic drinks per week. See Figure <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S1</xref> for additional details of the trial's eligibility criteria.</p>
              </sec>
              <sec id="jah38102-sec-0012">
                <title>Dietary Interventions</title>
                <p>Participants in the DASH‐Sodium trial were randomly assigned in a parallel‐arm design to the DASH diet or a typical American diet (control) in a 1:1 ratio; hence, for each individual, there are measurements on the same diet over 12 weeks. On their assigned diet, there were 3 periods, each lasting 4 weeks, in which participants ate 3 levels of sodium intake in random order using a crossover design. The 3 sodium levels were characterized as high (1.6 mg/kcal), intermediate (1.1 mg/kcal), and low (0.5 mg/kcal). At the end of each period, ≈4, 8, and 12 weeks after randomization, fasting blood specimens. Given the random order of sodium assignments, about a third of the participants were consuming each of the 3 sodium levels during each period (Table <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S1</xref>). This article focuses on trends in cardiac biomarkers by dietary pattern given that there were 3 points over the 12 weeks. Because the laboratory specimens were only collected at the end of each 4‐week sodium intake period, we could not assess trends in the biomarkers related to the different sodium levels.</p>
                <p>The DASH dietary pattern emphasizes potassium‐rich fruits and vegetables and low‐fat dairy products; it includes whole grains, poultry, fish, and nuts; and it is reduced in red meat, sweets, and sugar‐containing beverages. Accordingly, it was rich in potassium, magnesium, calcium, and fiber, and reduced in total fat, saturated fat, and cholesterol; it was also slightly increased in protein.<xref rid="jah38102-bib-0004" ref-type="bibr"><sup>4</sup></xref> The control diet was designed to reflect a dietary pattern and nutrient composition that is typical of what many people eat in the United States (Table <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S2</xref>).</p>
                <p>During a 2‐week run‐in and the 3 feeding periods, participants were provided with all meals (including cooked food and snacks) and were weighed daily to adjust energy intake as needed to maintain body weight throughout the study. All participants ate the high‐sodium control diet during the 2‐week run‐in period before randomization. Feeding periods were separated by an average 5‐day break, during which they ate their usual diets. Over 98% of participants completed each of the intervention periods.<xref rid="jah38102-bib-0009" ref-type="bibr"><sup>9</sup></xref>
</p>
              </sec>
              <sec id="jah38102-sec-0013">
                <title>Outcomes of Interest</title>
                <p>The primary outcomes of interest were hs‐cTnI, NT‐proBNP, and hs‐CRP. Baseline serum specimens were collected during the trial after a 12‐hour fast before feeding (while participants ate their usual diets) and at the end of each feeding period (ie, approximately weeks 4, 8, and 12 of the assigned dietary pattern). These outcomes were a specific aim of a National Institutes of Health R21 grant (R21HL144876) with an intent to publish made before examination of the data. Biospecimens were stored at −70 °C and underwent at least 1 freeze‐thaw cycle before the present measurements. Laboratory equipment for the biomarker assays was donated by Siemens Healthineers (Malvern, PA). The biomarker measurement was completed in 2019 using the following: (1) ADVIA Centaur High‐Sensitivity Troponin I (reported within‐run coefficient of variation of 4.8% for a mean of 13.11 ng/L [or pg/mL]); (2) Dimension Vista N‐Terminal Pro‐Brain Natriuretic Peptide (reported within‐run coefficient of variation of 1.4% for a mean 120 pg/mL); and (3) Dimension Vista High Sensitivity C‐Reactive Protein (reported within‐run coefficient of variation of 5.2% for a mean 2.39 mg/L). The manufacturer estimates of assay accuracy and precision performance have been previously reported.<xref rid="jah38102-bib-0012" ref-type="bibr"><sup>12</sup></xref> The limits of detection, as specified in the manufacturer laboratory insert, were as follows: &lt;1.60 ng/L (hs‐cTnI), &lt;5 pg/mL (NT‐proBNP), and &lt;0.160 mg/L (hs‐CRP). A large number of hs‐cTnI values were below the limit of detection of the ADVIA assay. We accounted for this by examining an alternate measurement cut point based on the assay's limit of blank (&lt;0.5 ng/L) rather than the limit of detection (&lt;1.60 ng/L), the rationale and details of which have been previously described.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref>
</p>
                <p>A total of 1547 specimens were available for our study, which comprises 93.9% of the 1648 specimens available for collection (412 participants with 4 visits). Of the available specimens, 1543 yielded results for all 3 biomarkers (93.6%). Missing data were evenly distributed across dietary assignments and time points (Figure <xref rid="jah38102-fig-0001" ref-type="fig">1</xref>).</p>
                <fig position="float" fig-type="Figure" id="jah38102-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <title>Specimen availability at baseline and according to follow‐up visits in the DASH–Sodium trial.</title>
                    <p>DASH indicates Dietary Approaches to Stop Hypertension.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e026684-g002" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
              <sec id="jah38102-sec-0014">
                <title>Covariates</title>
                <p>Blood pressure was measured using random‐zero sphygmomanometers while participants were seated. Baseline blood pressure was defined as the average of 5 pairs of measurements obtained across 3 visits in the screening phase and 2 visits in the 2‐week run‐in period. Hypertension was defined in this trial as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. Enzymatic calorimetry was used to measure high‐density lipoprotein cholesterol, triglycerides, and total cholesterol, whereas low‐density lipoprotein was estimated by the Friedewald equation.<xref rid="jah38102-bib-0013" ref-type="bibr"><sup>13</sup></xref> Body mass index was calculated from measured height and weight. Obesity was defined as a body mass index ≥30 kg/m<sup>2</sup>.</p>
              </sec>
              <sec id="jah38102-sec-0015">
                <title>Statistical Analysis</title>
                <p>Baseline population characteristics were described according to diet assignment using means (SDs) and proportions. Given data skew, the serum biomarkers were log transformed. Exponentiating the mean of a log‐transformed variable yields the geometric mean. We used mixed effects tobit models (metobit command) to determine the geometric mean of serum concentrations (SD) of the log‐transformed biomarkers. A tobit model was used to address informative left censoring that occurs below the limit of detection (or blank) for each assay, which allowed us to fit a linear regression model in the detectable range while designating undetectable biomarkers as below the detectable range.<xref rid="jah38102-bib-0014" ref-type="bibr"><sup>14</sup></xref> All models were left truncated for the limits of detection or blank (hs‐cTnI). The fixed portion of the tobit model included diet assignment (with value 0 for control or 1 for DASH), a visit variable (with values 0, 1, 2, and 3, corresponding to baseline and the end of the 3 feeding periods, spaced ≈4, 8, and 12 weeks after randomization), and the interaction of these terms. The random‐effects portion of the tobit model included participant identifier (introducing a random intercept).</p>
                <p>Trend analyses were performed using similar models by treating the visit variable as a continuous variable (versus a categorical variable for each visit). We further assessed for potential nonlinearity over time at the first visit, by using a linear spline with a single knot specified at 4 weeks to distinguish immediate changes from baseline from changes between 4 and 12 weeks. We compared coefficients of diet‐by‐time segment interactions (via the test command) to determine whether diet modified changes in biomarkers during the first 4 weeks differently from the latter 8 weeks.</p>
                <p>All analyses were conducted using Stata version 15.1 (Stata Corporation, College Station, TX).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jah38102-sec-0016">
              <title>Results</title>
              <sec id="jah38102-sec-0017">
                <title>Baseline Characteristics</title>
                <p>Baseline characteristics of the DASH‐Sodium trial participants by dietary assignment are shown in Table <xref rid="jah38102-tbl-0001" ref-type="table">1</xref>. There were minimal differences by randomized dietary assignment. One of the original participants was excluded because of lack of stored specimens (Figure <xref rid="jah38102-fig-0001" ref-type="fig">1</xref>).</p>
                <table-wrap position="float" id="jah38102-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Baseline Characteristics, According to Diet Assignment</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Characteristic</th>
                        <th align="left" rowspan="1" colspan="1">Control diet (N=204)</th>
                        <th align="left" rowspan="1" colspan="1">DASH diet (N=208)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, y</td>
                        <td align="left" rowspan="1" colspan="1">49.1 (10.4)</td>
                        <td align="left" rowspan="1" colspan="1">47.4 (9.6)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Women, %</td>
                        <td align="left" rowspan="1" colspan="1">54.4</td>
                        <td align="left" rowspan="1" colspan="1">59.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Black race, %</td>
                        <td align="left" rowspan="1" colspan="1">56.4</td>
                        <td align="left" rowspan="1" colspan="1">57.2</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">Blood pressure, mm Hg</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Systolic</td>
                        <td align="left" rowspan="1" colspan="1">135.4 (9.4)</td>
                        <td align="left" rowspan="1" colspan="1">134.2 (9.6)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Diastolic</td>
                        <td align="left" rowspan="1" colspan="1">85.8 (4.1)</td>
                        <td align="left" rowspan="1" colspan="1">85.6 (4.8)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1">Baseline SBP ≥140 mm Hg or DBP ≥90 mm Hg, %</td>
                        <td align="left" rowspan="1" colspan="1">40.7</td>
                        <td align="left" rowspan="1" colspan="1">40.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">High‐density lipoprotein cholesterol, mg/dL</td>
                        <td align="left" rowspan="1" colspan="1">48.1 (13.1)</td>
                        <td align="left" rowspan="1" colspan="1">48.5 (12.5)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1">Low‐density lipoprotein cholesterol, mg/dL<xref rid="jah38102-note-0005" ref-type="table-fn">*</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">131.8 (31.6)</td>
                        <td align="left" rowspan="1" colspan="1">130.7 (29.8)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Triglycerides, mg/dL</td>
                        <td align="left" rowspan="1" colspan="1">94.0 (67.0–140.5)</td>
                        <td align="left" rowspan="1" colspan="1">92.0 (67.0–130.5)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Total cholesterol, mg/dL</td>
                        <td align="left" rowspan="1" colspan="1">202.7 (36.0)</td>
                        <td align="left" rowspan="1" colspan="1">202.0 (36.4)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">29.5 (5.0)</td>
                        <td align="left" rowspan="1" colspan="1">28.8 (4.7)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Body mass index ≥30 kg/m<sup>2</sup>, %</td>
                        <td align="left" rowspan="1" colspan="1">40.2</td>
                        <td align="left" rowspan="1" colspan="1">37.5</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38102-ntgp-0002">
                    <fn id="jah38102-note-0004">
                      <p>Values are mean (SD), percentage, or median (25th–75th percentile). DASH indicates Dietary Approaches to Stop Hypertension; DBP, diastolic blood pressure; and SBP, systolic blood pressure.</p>
                    </fn>
                    <fn id="jah38102-note-0005">
                      <label>*</label>
                      <p>N=202 for the control diet and 204 for the DASH diet.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah38102-sec-0018">
                <title>Effects of the <styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet on Change in <styled-content style="fixed-case" toggle="no">hs‐cTnI</styled-content>
</title>
                <p>The mean baseline concentrations of hs‐cTnI, NT‐proBNP, and hs‐CRP were similar between those assigned to control and those assigned to DASH (Table <xref rid="jah38102-tbl-0002" ref-type="table">2</xref>). The control diet had no effect on hs‐cTnI at any of the measured time points. Among participants assigned the DASH diet, hs‐cTnI was reduced from baseline by 0.18 ng/L (95% CI, −0.32 to −0.04 ng/L) at 4 weeks, 0.14 ng/L (95% CI, −0.29 to 0.00 ng/L) at 8 weeks, and 0.33 ng/L (95% CI, −0.48 to −0.18 ng/L) at 12 weeks (Table <xref rid="jah38102-tbl-0002" ref-type="table">2</xref>). This pattern of change over time differed significantly from the control group (<italic toggle="yes">P‐</italic>interaction for DASH versus control trends=0.025) (Figure <xref rid="jah38102-fig-0002" ref-type="fig">2</xref>). There was no evidence that early trial effects (baseline to 4 weeks) differed by diet from later trial effects (4 to 12 weeks) (<italic toggle="yes">P</italic> trend for nonlinear effects=0.32). Percentage changes over time had a similar pattern (Table <xref rid="jah38102-tbl-0003" ref-type="table">3</xref>). Similar findings were observed in sensitivity analyses using the limit of blank rather than the limit of detection and after adjusting for sodium assignment (Tables <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S3 through S5</xref>). When comparing the DASH diet versus control, a statistically significant between‐diet difference in change from baseline levels of hs‐cTnI was not observed until week 12 (% difference, 17.78% [95% CI, −29.51% to −4.09%]) (Table <xref rid="jah38102-tbl-0003" ref-type="table">3</xref>).</p>
                <table-wrap position="float" id="jah38102-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Absolute Change From Baseline in Concentration of Cardiac Biomarkers by Visit, According to Diet Assignment (N=411 Unique Individuals)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variable</th>
                        <th align="left" rowspan="1" colspan="1">Control diet<xref rid="jah38102-note-0007" ref-type="table-fn">*</xref>
</th>
                        <th align="left" rowspan="1" colspan="1">DASH diet<xref rid="jah38102-note-0007" ref-type="table-fn">*</xref>
</th>
                        <th align="left" rowspan="1" colspan="1">Absolute difference<xref rid="jah38102-note-0008" ref-type="table-fn">†</xref>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">High‐sensitivity cardiac troponin I, ng/L</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Baseline<xref rid="jah38102-note-0009" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">1.68 (0.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.36 (0.15)</td>
                        <td align="left" rowspan="1" colspan="1">−0.32 (−0.73 to 0.09)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 4 wk</td>
                        <td align="left" rowspan="1" colspan="1">−0.00 (−0.18 to 0.17)</td>
                        <td align="left" rowspan="1" colspan="1">−0.18 (−0.32 to −0.04)</td>
                        <td align="left" rowspan="1" colspan="1">−0.18 (−0.38 to 0.02)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 8 wk</td>
                        <td align="left" rowspan="1" colspan="1">0.00 (−0.18 to 0.18)</td>
                        <td align="left" rowspan="1" colspan="1">−0.14 (−0.29 to 0.00)</td>
                        <td align="left" rowspan="1" colspan="1">−0.14 (−0.34 to 0.06)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 12 wk</td>
                        <td align="left" rowspan="1" colspan="1">−0.13 (−0.30 to 0.04)</td>
                        <td align="left" rowspan="1" colspan="1">−0.33 (−0.48 to −0.18)</td>
                        <td align="left" rowspan="1" colspan="1">−0.22 (−0.41 to −0.03)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">NT‐proBNP, pg/mL</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Baseline<xref rid="jah38102-note-0009" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">28.65 (1.89)</td>
                        <td align="left" rowspan="1" colspan="1">28.95 (1.90)</td>
                        <td align="left" rowspan="1" colspan="1">0.30 (−4.95 to 5.54)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 4 wk</td>
                        <td align="left" rowspan="1" colspan="1">−6.01 (−8.50 to −3.53)</td>
                        <td align="left" rowspan="1" colspan="1">−6.46 (−8.97 to −3.95)</td>
                        <td align="left" rowspan="1" colspan="1">−0.38 (−3.37 to 2.60)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 8 wk</td>
                        <td align="left" rowspan="1" colspan="1">−4.21 (−6.76 to −1.67)</td>
                        <td align="left" rowspan="1" colspan="1">−5.55 (−8.09 to −3.01)</td>
                        <td align="left" rowspan="1" colspan="1">−1.29 (−4.53 to 1.95)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 12 wk</td>
                        <td align="left" rowspan="1" colspan="1">−4.88 (−7.43 to −2.33)</td>
                        <td align="left" rowspan="1" colspan="1">−6.76 (−9.27 to −4.24)</td>
                        <td align="left" rowspan="1" colspan="1">−1.83 (−4.98 to 1.32)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">hs‐CRP, mg/L</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Baseline<xref rid="jah38102-note-0009" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">2.06 (0.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.94 (0.17)</td>
                        <td align="left" rowspan="1" colspan="1">−0.13 (−0.61 to 0.35)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 4 wk</td>
                        <td align="left" rowspan="1" colspan="1">−0.10 (−0.33 to 0.13)</td>
                        <td align="left" rowspan="1" colspan="1">−0.27 (−0.48 to −0.06)</td>
                        <td align="left" rowspan="1" colspan="1">−0.18 (−0.47 to 0.11)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 8 wk</td>
                        <td align="left" rowspan="1" colspan="1">0.01 (−0.23 to 0.25)</td>
                        <td align="left" rowspan="1" colspan="1">−0.18 (−0.39 to 0.03)</td>
                        <td align="left" rowspan="1" colspan="1">−0.19 (−0.50 to 0.12)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 12 wk</td>
                        <td align="left" rowspan="1" colspan="1">0.02 (−0.22 to 0.26)</td>
                        <td align="left" rowspan="1" colspan="1">−0.37 (−0.58 to −0.16)</td>
                        <td align="left" rowspan="1" colspan="1">−0.39 (−0.70 to −0.08)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38102-ntgp-0003">
                    <fn id="jah38102-note-0006">
                      <p>Values are number (95% CI), unless otherwise indicated. There were 1545 high‐sensitivity troponin I and hs‐CRP measurements and 1547 NT‐proBNP measurements. DASH indicates Dietary Approaches to Stop Hypertension; hs‐CRP, high‐sensitivity C‐reactive protein; and NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.</p>
                    </fn>
                    <fn id="jah38102-note-0007">
                      <label>*</label>
                      <p>Difference in exponentiated log‐transformed markers (ie, difference in geometric means).</p>
                    </fn>
                    <fn id="jah38102-note-0008">
                      <label>†</label>
                      <p>The absolute difference may not directly compute from values listed in the table because of transformation and rounding of exponentiated log‐transformed markers.</p>
                    </fn>
                    <fn id="jah38102-note-0009">
                      <label>
                        <sup>
                          <sans-serif>‡</sans-serif>
                        </sup>
                      </label>
                      <p>Baseline cardiac biomarkers presented as geometric mean (SE).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="jah38102-fig-0002">
                  <label>Figure 2</label>
                  <caption>
                    <title>Effects of the DASH diet on hs‐cTnI over time.</title>
                    <p>Geometric means (95% CIs) of hs‐cTnI (ng/L), a marker of cardiac injury, according to diet assignment at baseline and the end of 3 feeding periods, ≈4, 8, and 12 weeks after randomization. Means are estimated using mixed‐effect tobit models. The <italic toggle="yes">P</italic> interaction for trend is derived from an interaction term in the model between diet and visit. The dashed (control) and solid (DASH) lines represent a linear fit of the geometric means. DASH indicates Dietary Approaches to Stop Hypertension; and hs‐cTnI, high‐sensitivity cardiac troponin I.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e026684-g003" position="anchor" id="jats-graphic-3"/>
                </fig>
                <table-wrap position="float" id="jah38102-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>Geometric Means, Percentage Change From Baseline, and Percentage Difference in Cardiac Biomarkers by Visit, Comparing the DASH Diet With the Control Diet (N=411 Unique Individuals)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" style="border-bottom:solid 1px #000000" rowspan="1" colspan="1"/>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">Geometric mean (SE)<xref rid="jah38102-note-0011" ref-type="table-fn">*</xref>
</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">% Change from baseline (95% CI)<xref rid="jah38102-note-0012" ref-type="table-fn">†</xref>
</th>
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Between‐diet comparison, % difference (95% CI)<xref rid="jah38102-note-0013" ref-type="table-fn">‡</xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Variable</th>
                        <th align="left" rowspan="1" colspan="1">Control diet</th>
                        <th align="left" rowspan="1" colspan="1">DASH diet</th>
                        <th align="left" rowspan="1" colspan="1">Control diet</th>
                        <th align="left" rowspan="1" colspan="1">DASH diet</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">High‐sensitivity cardiac troponin I, ng/L</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">1.68 (0.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.36 (0.15)</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 4 wk</td>
                        <td align="left" rowspan="1" colspan="1">1.67 (0.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.17 (0.13)</td>
                        <td align="left" rowspan="1" colspan="1">−0.16 (−9.94 to 10.68)</td>
                        <td align="left" rowspan="1" colspan="1">−13.44 (−22.33 to −3.53)</td>
                        <td align="left" rowspan="1" colspan="1">−13.30 (−25.34 to 0.69)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 8 wk</td>
                        <td align="left" rowspan="1" colspan="1">1.68 (0.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.22 (0.13)</td>
                        <td align="left" rowspan="1" colspan="1">0.05 (−9.93 to 11.13)</td>
                        <td align="left" rowspan="1" colspan="1">−10.42 (−19.73 to −0.04)</td>
                        <td align="left" rowspan="1" colspan="1">−10.47 (−23.08 to 4.21)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 12 wk</td>
                        <td align="left" rowspan="1" colspan="1">1.55 (0.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.03 (0.11)</td>
                        <td align="left" rowspan="1" colspan="1">−7.74 (−17.09 to 2.66)</td>
                        <td align="left" rowspan="1" colspan="1">−24.14 (−32.11 to −15.24)</td>
                        <td align="left" rowspan="1" colspan="1">−17.78 (−29.51 to −4.09)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">NT‐proBNP, pg/mL</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">28.65 (1.89)</td>
                        <td align="left" rowspan="1" colspan="1">28.95 (1.90)</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 4 wk</td>
                        <td align="left" rowspan="1" colspan="1">22.64 (1.49)</td>
                        <td align="left" rowspan="1" colspan="1">22.49 (1.48)</td>
                        <td align="left" rowspan="1" colspan="1">−20.99 (−27.97 to −13.33)</td>
                        <td align="left" rowspan="1" colspan="1">−22.31 (−29.20 to −14.75)</td>
                        <td align="left" rowspan="1" colspan="1">−1.67 (−13.75 to 12.10)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 8 wk</td>
                        <td align="left" rowspan="1" colspan="1">24.44 (1.62)</td>
                        <td align="left" rowspan="1" colspan="1">23.41 (1.54)</td>
                        <td align="left" rowspan="1" colspan="1">−14.70 (−22.37 to −6.28)</td>
                        <td align="left" rowspan="1" colspan="1">−19.16 (−26.39 to −11.21)</td>
                        <td align="left" rowspan="1" colspan="1">−5.22 (−17.01 to 8.25)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 12 wk</td>
                        <td align="left" rowspan="1" colspan="1">23.78 (1.59)</td>
                        <td align="left" rowspan="1" colspan="1">22.19 (1.46)</td>
                        <td align="left" rowspan="1" colspan="1">−17.02 (−24.56 to −8.74)</td>
                        <td align="left" rowspan="1" colspan="1">−23.34 (−30.16 to −15.85)</td>
                        <td align="left" rowspan="1" colspan="1">−7.61 (−19.14 to 5.55)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="6" rowspan="1">hs‐CRP, mg/L</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Baseline</td>
                        <td align="left" rowspan="1" colspan="1">2.06 (0.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.94 (0.17)</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                        <td align="left" rowspan="1" colspan="1">Reference</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 4 wk</td>
                        <td align="left" rowspan="1" colspan="1">1.97 (0.17)</td>
                        <td align="left" rowspan="1" colspan="1">1.67 (0.14)</td>
                        <td align="left" rowspan="1" colspan="1">−4.72 (−14.89 to 6.66)</td>
                        <td align="left" rowspan="1" colspan="1">−13.87 (−23.07 to −3.57)</td>
                        <td align="left" rowspan="1" colspan="1">−9.60 (−22.94 to 6.05)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 8 wk</td>
                        <td align="left" rowspan="1" colspan="1">2.07 (0.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.75 (0.15)</td>
                        <td align="left" rowspan="1" colspan="1">0.53 (−10.37 to 12.76)</td>
                        <td align="left" rowspan="1" colspan="1">−9.41 (−19.18 to 1.54)</td>
                        <td align="left" rowspan="1" colspan="1">−9.89 (−23.35 to 5.94)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Change at 12 wk</td>
                        <td align="left" rowspan="1" colspan="1">2.09 (0.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.57 (0.13)</td>
                        <td align="left" rowspan="1" colspan="1">1.06 (−10.01 to 13.48)</td>
                        <td align="left" rowspan="1" colspan="1">−19.12 (−27.77 to −9.43)</td>
                        <td align="left" rowspan="1" colspan="1">−19.97 (−31.94 to −5.89)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38102-ntgp-0004">
                    <fn id="jah38102-note-0010">
                      <p>There were 1545 high‐sensitivity troponin I and hs‐CRP measurements and 1547 NT‐proBNP measurements. DASH indicates Dietary Approaches to Stop Hypertension; hs‐CRP, high‐sensitivity C‐reactive protein; and NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.</p>
                    </fn>
                    <fn id="jah38102-note-0011">
                      <label>*</label>
                      <p>Exponentiated log‐transformed markers or the geometric mean.</p>
                    </fn>
                    <fn id="jah38102-note-0012">
                      <label>†</label>
                      <p>Exponentiated differences of the change on the log scale.</p>
                    </fn>
                    <fn id="jah38102-note-0013">
                      <label>
                        <sup>
                          <sans-serif>‡</sans-serif>
                        </sup>
                      </label>
                      <p>The percentage difference may not directly compute from those listed in the table because of transformation and rounding of exponentiated log‐transformed markers.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah38102-sec-0019">
                <title>Effects of the <styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet on Change in <styled-content style="fixed-case" toggle="no">NT‐proBNP</styled-content>
</title>
                <p>In both the control and DASH diets, levels of NT‐proBNP were reduced at weeks 4, 8, and 12 in comparison to baseline values; however, there were no significant differences between diets (<italic toggle="yes">P‐</italic>interaction for trend=0.22) or evidence that dietary effects differed the first 4 weeks from the latter 8 weeks (<italic toggle="yes">P</italic> trend for nonlinear effects=0.87) (Figure <xref rid="jah38102-fig-0003" ref-type="fig">3</xref> and Tables <xref rid="jah38102-tbl-0002" ref-type="table">2</xref> and <xref rid="jah38102-tbl-0003" ref-type="table">3</xref>). Findings were similar in a sensitivity analysis adjusting for sodium assignment (Tables <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S4</xref> and <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S5</xref>).</p>
                <fig position="float" fig-type="Figure" id="jah38102-fig-0003">
                  <label>Figure 3</label>
                  <caption>
                    <title>Effects of the DASH diet on NT‐proBNP over time.</title>
                    <p>Geometric means (95% CIs) of NT‐proBNP (pg/mL), a marker of cardiac strain, according to diet assignment at baseline and the end of 3 feeding periods, spaced ≈4, 8, and 12 weeks after randomization. Means are estimated using mixed‐effect tobit models. The <italic toggle="yes">P</italic> interaction for trend is derived from an interaction term in the model between diet and visit. The dashed (control) and solid (DASH) lines represent a linear fit of the geometric means. DASH indicates Dietary Approaches to Stop Hypertension; and NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e026684-g004" position="anchor" id="jats-graphic-5"/>
                </fig>
              </sec>
              <sec id="jah38102-sec-0020">
                <title>Effects of the <styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet on Change in <styled-content style="fixed-case" toggle="no">hs‐CRP</styled-content>
</title>
                <p>Among those assigned the control diet, levels of hs‐CRP during follow‐up did not differ from baseline levels (Table <xref rid="jah38102-tbl-0002" ref-type="table">2</xref>). In contrast, among those assigned the DASH diet, reduction in hs‐CRP occurred by week 4 (−0.27 mg/L [95% CI, −0.48 to −0.06 mg/L]) and was further reduced at week 12 (−0.37 mg/L [95% CI, −0.58 to −0.16 mg/L]) (Table <xref rid="jah38102-tbl-0002" ref-type="table">2</xref>). This pattern of change differed significantly from the control group (<italic toggle="yes">P‐</italic>interaction for trend=0.01), with no evidence that dietary effects differed the first 4 weeks from the latter 8 weeks (<italic toggle="yes">P</italic> trend for nonlinear effects=0.85) (Figure <xref rid="jah38102-fig-0004" ref-type="fig">4</xref>). A similar pattern was evident when the analyses were conducted on a relative scale (Table <xref rid="jah38102-tbl-0003" ref-type="table">3</xref>). Findings were also similar in a sensitivity analysis adjusting for sodium assignment (Tables <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S4</xref> and <xref rid="jah38102-supitem-0001" ref-type="supplementary-material">S5</xref>). When comparing the DASH diet with control diet, a statistically significant between‐diet difference in change from baseline levels of hs‐CRP was not observed until week 12 (% difference, −19.97% [95% CI, −31.94% to −5.89%]) (Table <xref rid="jah38102-tbl-0003" ref-type="table">3</xref>).</p>
                <fig position="float" fig-type="Figure" id="jah38102-fig-0004">
                  <label>Figure 4</label>
                  <caption>
                    <title>Effects of the DASH diet on hs‐CRP over time.</title>
                    <p>Geometric means (95% CIs) of hs‐CRP (mg/L), a marker of inflammation, according to diet assignment at baseline and the end of 3 feeding periods, spaced ≈4, 8, and 12 weeks after randomization. Means are estimated using mixed‐effect tobit models. The <italic toggle="yes">P</italic> interaction for trend is derived from an interaction term in the model between diet and visit. The dashed (control) and solid (DASH) lines represent a linear fit of the geometric means. DASH indicates Dietary Approaches to Stop Hypertension; and hs‐CRP, high‐sensitivity C‐reactive protein.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e026684-g001" position="anchor" id="jats-graphic-7"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jah38102-sec-0021">
              <title>Discussion</title>
              <p>In this randomized trial of adults with elevated blood pressure or hypertension, in comparison with a typical American diet, the DASH diet reduced hs‐cTnI and hs‐CRP progressively over a 12‐week period. These observations suggest that the benefits of the DASH diet are not only maintained over time but potentially underestimated by short‐term feeding studies. Although longer‐term evidence is needed, these findings offer a compelling rationale for sustained adherence to the DASH diet to promote cardiovascular health.</p>
              <p>Several recent analyses of controlled feeding studies have demonstrated that DASH‐pattern diets reduce biomarkers of subclinical cardiac injury<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="jah38102-bib-0012" ref-type="bibr"><sup>12</sup></xref>, <xref rid="jah38102-bib-0015" ref-type="bibr"><sup>15</sup></xref> and inflammation.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="jah38102-bib-0015" ref-type="bibr"><sup>15</sup></xref> The OmniHeart trial showed that 3 DASH‐pattern diets emphasizing different macronutrient proportions reduced hs‐cTnI and hs‐CRP after 6 weeks of feeding.<xref rid="jah38102-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="jah38102-bib-0016" ref-type="bibr"><sup>16</sup></xref> In the DASH trial, the DASH diet was found to reduce hs‐cTnI after 8 weeks of feeding, but there were no effects on hs‐CRP.<xref rid="jah38102-bib-0012" ref-type="bibr"><sup>12</sup></xref> Most recently, in the DASH‐Sodium trial, which examined DASH dietary effects independent of sodium, the DASH diet lowered hs‐cTnI and hs‐CRP over 12 weeks of feeding.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref> However, these prior studies did not address how soon effects on hs‐cTnI and hs‐CRP might be realized by adopting the DASH diet or whether they were sustained over time, 2 of the main focuses of the present analysis.</p>
              <p>Several population‐based studies have shown that adherence to the DASH diet is associated with a lower risk of CVD events,<xref rid="jah38102-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jah38102-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38102-bib-0007" ref-type="bibr"><sup>7</sup></xref> which is likely mediated in large part by the effects of the DASH diet on blood pressure and cholesterol.<xref rid="jah38102-bib-0004" ref-type="bibr"><sup>4</sup></xref> However, our recent work suggests that the DASH diet may directly reduce subclinical cardiac damage.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="jah38102-bib-0012" ref-type="bibr"><sup>12</sup></xref>, <xref rid="jah38102-bib-0015" ref-type="bibr"><sup>15</sup></xref> Notably, biomarkers of subclinical myocardial damage, including hs‐cTnI, may provide prognostic information on long‐term CVD risk, independent of traditional risk factors.<xref rid="jah38102-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jah38102-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jah38102-bib-0019" ref-type="bibr"><sup>19</sup></xref> We found that the DASH diet reduced hs‐cTnI gradually over time in a trend that differed significantly from the control group. In the between‐diet comparison, the DASH diet significantly reduced hs‐cTnI from baseline at 12 weeks, whereas the changes at weeks 4 and 8 were modest and nonsignificant. Taken together, our findings suggest that benefits occur quickly and increase progressively over time. Although the time course of change in traditional risk factors (ie, blood pressure) from healthy dietary interventions has been evaluated,<xref rid="jah38102-bib-0020" ref-type="bibr"><sup>20</sup></xref> to our knowledge, there have been no studies on the time course of change in hs‐cTnI from a healthy dietary pattern before the present analysis.</p>
              <p>Inflammation is an established risk factor in the pathogenesis of atherosclerotic CVD, and several large observational studies have demonstrated the ability of hs‐CRP to predict CVD events independently of conventional risk factors.<xref rid="jah38102-bib-0021" ref-type="bibr"><sup>21</sup></xref> Moreover, greater cumulative exposure to elevated hs‐CRP levels is associated with a higher risk of CVD events.<xref rid="jah38102-bib-0022" ref-type="bibr"><sup>22</sup></xref> Similar to hs‐cTnI, we observed a modest, nonsignificant reduction in hs‐CRP at weeks 4 and 8 and a significant reduction at week 12 in participants assigned to the DASH diet. Although prior analyses of DASH feeding interventions found greater reductions in biomarkers of systemic inflammation in trials ≥8 weeks,<xref rid="jah38102-bib-0023" ref-type="bibr"><sup>23</sup></xref>, <xref rid="jah38102-bib-0024" ref-type="bibr"><sup>24</sup></xref> our study suggests that at least 12 weeks may be necessary to achieve the full effects of the DASH diet on hs‐CRP.</p>
              <p>In our prior analysis of DASH‐Sodium trial, sodium reduction alone reduced NT‐proBNP, whereas the DASH diet did not have a significant effect on NT‐proBNP compared with the control diet.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref> We found that NT‐proBNP was reduced at all time points for both the DASH and control diets. This likely reflects the fact that two‐thirds of participants were on lower than typical sodium intakes at all times in the trial and is consistent with our previous findings that DASH did not lower NT‐proBNP.<xref rid="jah38102-bib-0010" ref-type="bibr"><sup>10</sup></xref> Notably, the time course of change in NT‐proBNP appeared to differ from the trends in hs‐cTnI and hs‐CRP from the DASH diet; the maximal effect on NT‐proBNP was observed quickly, whereas the effects of the DASH diet on hs‐cTnI and hs‐CRP appeared to increase progressively.</p>
              <p>Our study has limitations. First, the duration of the DASH‐Sodium trial was relatively short, which limited our ability to determine whether the effects of the DASH diet on hs‐cTnI and hs‐CRP would continue to grow beyond 12 weeks. Second, because the duration of each level of sodium consumption was only 4 weeks, we were unable to evaluate the effects of sodium reduction on the time course of change in these biomarkers, which is particularly relevant for NT‐proBNP. Third, measurements of biomarkers were performed using stored serum samples from the DASH‐Sodium trial; however, studies suggest stability of these biomarkers in the setting of long‐term storage and freeze‐thaw cycles.<xref rid="jah38102-bib-0025" ref-type="bibr"><sup>25</sup></xref>, <xref rid="jah38102-bib-0026" ref-type="bibr"><sup>26</sup></xref>, <xref rid="jah38102-bib-0027" ref-type="bibr"><sup>27</sup></xref> Moreover, any drift would more likely bias our findings toward the null. Fourth, because NT‐proBNP is a biologically inactive cleavage counterpart of the active peptide B‐type natriuretic peptide, it is possible that B‐type natriuretic peptide may be a more relevant biomarker of cardiac pathophysiological features than NT‐proBNP. However, levels of NT‐proBNP and B‐type natriuretic peptide correlate sufficiently, and either may be used clinically for the diagnosis, risk stratification, and prognosis of heart failure.<xref rid="jah38102-bib-0028" ref-type="bibr"><sup>28</sup></xref> Moreover, the measurement of B‐type natriuretic peptide is limited by its relative instability in vivo and in vitro as well as by interference of inactive forms of the peptide in commercial immunoassays.<xref rid="jah38102-bib-0029" ref-type="bibr"><sup>29</sup></xref> Fifth, there is analytical variability among commercially available hs‐cTnI assays, particularly in the range of biomarker values below the 99th percentile value.<xref rid="jah38102-bib-0030" ref-type="bibr"><sup>30</sup></xref>, <xref rid="jah38102-bib-0031" ref-type="bibr"><sup>31</sup></xref> Although we were unable to perform head‐to‐head comparisons of the ADVIA Centaur assay with other hs‐cTnI assays, we accounted for potential intra‐assay precision variability at lower mean values of hs‐cTnI by performing a sensitivity analysis using the less precise limit of blank, which yielded similar results to our analysis using the limit of detection. Nevertheless, future studies evaluating the effects of the DASH diet on hs‐cTnI would benefit from confirmation using other hs‐cTnI methods. Sixth, in this secondary analysis of the main trial data, we did not adjust for multiplicity of comparisons, and our findings may be subject to type I error. Finally, individuals with established CVD were excluded from the trial, thus limiting the generalizability of our findings.</p>
              <p>Strengths of our study include the DASH‐Sodium trial's rigorous design, with tightly controlled dietary interventions, high rates of follow‐up, and data completeness. Second, energy intake was adjusted during the trial to maintain body weight, thus allowing us to evaluate the effects of the DASH diet on CVD biomarkers independent of weight loss. Third, serum specimens were collected at the end of each 4‐week sodium sequence in the context of the assigned dietary intervention, which allowed us to evaluate the time course of change in biomarkers from the DASH diet at 3 points over a 12‐week period.</p>
              <p>This study has clinical implications. First, patients often inquire about the time frame of expected benefits after beginning the DASH diet. Our study provides information on the time course of the DASH diet's effects on subclinical myocardial injury and systemic inflammation, which may enhance the ability of clinicians to effectively communicate the cardiovascular health benefits of the DASH diet. Second, the progressive benefits on hs‐cTnI and hs‐CRP observed in our study highlight the importance of sustained adherence to the DASH diet and the need for innovative strategies and system‐wide policies to support its adoption. Finally, our study may inform the design of future longitudinal studies evaluating the long‐term effects of the DASH diet on cardiac biomarkers.</p>
              <p>In conclusion, in comparison with a typical American diet, the DASH diet reduced hs‐cTnI and hs‐CRP progressively over a 12‐week period, suggesting that the DASH diet has cumulative benefits over time on biomarkers of subclinical cardiac injury and inflammation. These findings provide further insight into the positive effects of the DASH diet on subclinical cardiac injury and inflammation and highlight the need for public health policies and interventions that support sustained adherence to a healthy eating pattern for cardiovascular health.</p>
            </sec>
            <sec id="jah38102-sec-0023">
              <title>Sources of Funding</title>
              <p>The measurement of cardiac biomarkers was supported by the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) R21HL144876. The original DASH (Dietary Approaches to Stop Hypertension) trial was supported by grants (HL50981, HL50968, HL50972, HL50977, HL50982, HL02642, RR02635, and RR00722) from the NHLBI, the Office of Research on Minority Health, and the National Center for Research Resources of the NIH. Siemens (Siemens Healthineers, Malvern, PA) donated test assays and kits for the 3 cardiac biomarkers measured in this study. Dr Juraschek is supported by NIH/NHLBI K23HL135273.</p>
            </sec>
            <sec id="jah38102-sec-0024">
              <title>Disclosures</title>
              <p>None.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="jah38102-supitem-0001" position="float" content-type="local-data">
                <caption>
                  <p>Tables S1–S5</p>
                  <p>Figure S1</p>
                </caption>
                <media xlink:href="JAH3-12-e026684-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jah38102-sec-0022">
              <title>Acknowledgments</title>
              <p>The authors are indebted to the study participants for their sustained commitment to the DASH (Dietary Approaches to Stop Hypertension)–Sodium trial.</p>
            </ack>
            <ref-list content-type="cited-references" id="jah38102-bibl-0001">
              <title>References</title>
              <ref id="jah38102-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0001"><string-name><surname>Virani</surname><given-names>SS</given-names></string-name>, <string-name><surname>Alonso</surname><given-names>A</given-names></string-name>, <string-name><surname>Aparicio</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Benjamin</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Bittencourt</surname><given-names>MS</given-names></string-name>, <string-name><surname>Callaway</surname><given-names>CW</given-names></string-name>, <string-name><surname>Carson</surname><given-names>AP</given-names></string-name>, <string-name><surname>Chamberlain</surname><given-names>AM</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>S</given-names></string-name>, <string-name><surname>Delling</surname><given-names>FN</given-names></string-name>, et al. <article-title>Heart disease and stroke statistics‐2021 update: a report from the American Heart Association</article-title>. <source>Circulation.</source><year>2021</year>;<volume>143</volume>:<fpage>e254</fpage>–<lpage>e743</lpage>. doi: <pub-id pub-id-type="doi">10.1161/cir.0000000000000950</pub-id>
<pub-id pub-id-type="pmid">33501848</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0002"><string-name><surname>Yusuf</surname><given-names>S</given-names></string-name>, <string-name><surname>Joseph</surname><given-names>P</given-names></string-name>, <string-name><surname>Rangarajan</surname><given-names>S</given-names></string-name>, <string-name><surname>Islam</surname><given-names>S</given-names></string-name>, <string-name><surname>Mente</surname><given-names>A</given-names></string-name>, <string-name><surname>Hystad</surname><given-names>P</given-names></string-name>, <string-name><surname>Brauer</surname><given-names>M</given-names></string-name>, <string-name><surname>Kutty</surname><given-names>VR</given-names></string-name>, <string-name><surname>Gupta</surname><given-names>R</given-names></string-name>, <string-name><surname>Wielgosz</surname><given-names>A</given-names></string-name>, et al. <article-title>Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high‐income, middle‐income, and low‐income countries (PURE): a prospective cohort study</article-title>. <source>Lancet.</source><year>2020</year>;<volume>395</volume>:<fpage>795</fpage>–<lpage>808</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0140-6736(19)32008-2</pub-id>
<pub-id pub-id-type="pmid">31492503</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0003"><string-name><surname>Murray</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Atkinson</surname><given-names>C</given-names></string-name>, <string-name><surname>Bhalla</surname><given-names>K</given-names></string-name>, <string-name><surname>Birbeck</surname><given-names>G</given-names></string-name>, <string-name><surname>Burstein</surname><given-names>R</given-names></string-name>, <string-name><surname>Chou</surname><given-names>D</given-names></string-name>, <string-name><surname>Dellavalle</surname><given-names>R</given-names></string-name>, <string-name><surname>Danaei</surname><given-names>G</given-names></string-name>, <string-name><surname>Ezzati</surname><given-names>M</given-names></string-name>, <string-name><surname>Fahimi</surname><given-names>A</given-names></string-name>, et al. <article-title>The state of US health, 1990‐2010: burden of diseases, injuries, and risk factors</article-title>. <source>JAMA.</source><year>2013</year>;<volume>310</volume>:<fpage>591</fpage>–<lpage>608</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2013.13805</pub-id>
<pub-id pub-id-type="pmid">23842577</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0004"><string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Moore</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Vogt</surname><given-names>TM</given-names></string-name>, <string-name><surname>Cutler</surname><given-names>JA</given-names></string-name>, <string-name><surname>Windhauser</surname><given-names>MM</given-names></string-name>, et al. <article-title>A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group</article-title>. <source>N Engl J Med.</source><year>1997</year>;<volume>336</volume>:<fpage>1117</fpage>–<lpage>1124</lpage>. doi: <pub-id pub-id-type="doi">10.1056/nejm199704173361601</pub-id>
<pub-id pub-id-type="pmid">9099655</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0005"><string-name><surname>Fung</surname><given-names>TT</given-names></string-name>, <string-name><surname>Chiuve</surname><given-names>SE</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>ML</given-names></string-name>, <string-name><surname>Rexrode</surname><given-names>KM</given-names></string-name>, <string-name><surname>Logroscino</surname><given-names>G</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name>. <article-title>Adherence to a DASH‐style diet and risk of coronary heart disease and stroke in women</article-title>. <source>Arch Intern Med.</source><year>2008</year>;<volume>168</volume>:<fpage>713</fpage>–<lpage>720</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinte.168.7.713</pub-id>
<pub-id pub-id-type="pmid">18413553</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0006"><string-name><surname>Sotos‐Prieto</surname><given-names>M</given-names></string-name>, <string-name><surname>Bhupathiraju</surname><given-names>SN</given-names></string-name>, <string-name><surname>Mattei</surname><given-names>J</given-names></string-name>, <string-name><surname>Fung</surname><given-names>TT</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Pan</surname><given-names>A</given-names></string-name>, <string-name><surname>Willett</surname><given-names>WC</given-names></string-name>, <string-name><surname>Rimm</surname><given-names>EB</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name>. <article-title>Association of changes in diet quality with total and cause‐specific mortality</article-title>. <source>N Engl J Med.</source><year>2017</year>;<volume>377</volume>:<fpage>143</fpage>–<lpage>153</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1613502</pub-id>
<pub-id pub-id-type="pmid">28700845</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0007"><string-name><surname>Folsom</surname><given-names>AR</given-names></string-name>, <string-name><surname>Parker</surname><given-names>ED</given-names></string-name>, <string-name><surname>Harnack</surname><given-names>LJ</given-names></string-name>. <article-title>Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease</article-title>. <source>Am J Hypertens.</source><year>2007</year>;<volume>20</volume>:<fpage>225</fpage>–<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amjhyper.2006.09.003</pub-id>
<pub-id pub-id-type="pmid">17324731</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0008"><string-name><surname>Lloyd‐Jones</surname><given-names>DM</given-names></string-name>, <string-name><surname>Hong</surname><given-names>Y</given-names></string-name>, <string-name><surname>Labarthe</surname><given-names>D</given-names></string-name>, <string-name><surname>Mozaffarian</surname><given-names>D</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Van Horn</surname><given-names>L</given-names></string-name>, <string-name><surname>Greenlund</surname><given-names>K</given-names></string-name>, <string-name><surname>Daniels</surname><given-names>S</given-names></string-name>, <string-name><surname>Nichol</surname><given-names>G</given-names></string-name>, <string-name><surname>Tomaselli</surname><given-names>GF</given-names></string-name>, et al. <article-title>Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond</article-title>. <source>Circulation.</source><year>2010</year>;<volume>121</volume>:<fpage>586</fpage>–<lpage>613</lpage>. doi: <pub-id pub-id-type="doi">10.1161/circulationaha.109.192703</pub-id>
<pub-id pub-id-type="pmid">20089546</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0009"><string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Harsha</surname><given-names>D</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Conlin</surname><given-names>PR</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Simons‐Morton</surname><given-names>DG</given-names></string-name>, et al. <article-title>Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH‐sodium collaborative research group</article-title>. <source>N Engl J Med.</source><year>2001</year>;<volume>344</volume>:<fpage>3</fpage>–<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1056/nejm200101043440101</pub-id>
<pub-id pub-id-type="pmid">11136953</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0010"><string-name><surname>Juraschek</surname><given-names>SP</given-names></string-name>, <string-name><surname>Kovell</surname><given-names>LC</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Chang</surname><given-names>AR</given-names></string-name>, <string-name><surname>Christenson</surname><given-names>RH</given-names></string-name>, <string-name><surname>Rebuck</surname><given-names>H</given-names></string-name>, <string-name><surname>Mukamal</surname><given-names>KJ</given-names></string-name>. <article-title>Effects of diet and sodium reduction on cardiac injury, strain, and inflammation: the DASH‐sodium trial</article-title>. <source>J Am Coll Cardiol.</source><year>2021</year>;<volume>77</volume>:<fpage>2625</fpage>–<lpage>2634</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2021.03.320</pub-id>
<pub-id pub-id-type="pmid">34045018</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0011"><string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Lin</surname><given-names>PH</given-names></string-name>, <string-name><surname>Karanja</surname><given-names>NM</given-names></string-name>, <string-name><surname>Harsha</surname><given-names>DW</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Aickin</surname><given-names>M</given-names></string-name>, et al. <article-title>The DASH diet, sodium intake and blood pressure trial (DASH‐sodium): rationale and design. DASH‐sodium collaborative research group</article-title>. <source>J Am Diet Assoc.</source><year>1999</year>;<volume>99</volume>:<fpage>S96</fpage>–<lpage>S104</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0002-8223(99)00423-x</pub-id>
<pub-id pub-id-type="pmid">10450301</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0012"><string-name><surname>Juraschek</surname><given-names>SP</given-names></string-name>, <string-name><surname>Kovell</surname><given-names>LC</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Christenson</surname><given-names>RH</given-names></string-name>, <string-name><surname>Rebuck</surname><given-names>H</given-names></string-name>, <string-name><surname>Chang</surname><given-names>AR</given-names></string-name>, <string-name><surname>Mukamal</surname><given-names>KJ</given-names></string-name>. <article-title>Associations between dietary patterns and subclinical cardiac injury: an observational analysis from the DASH trial</article-title>. <source>Ann Intern Med.</source><year>2020</year>;<volume>172</volume>:<fpage>786</fpage>–<lpage>794</lpage>. doi: <pub-id pub-id-type="doi">10.7326/m20-0336</pub-id>
<pub-id pub-id-type="pmid">32423348</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0013"><string-name><surname>Friedewald</surname><given-names>WT</given-names></string-name>, <string-name><surname>Levy</surname><given-names>RI</given-names></string-name>, <string-name><surname>Fredrickson</surname><given-names>DS</given-names></string-name>. <article-title>Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title>. <source>Clin Chem.</source><year>1972</year>;<volume>18</volume>:<fpage>499</fpage>–<lpage>502</lpage>. doi: <pub-id pub-id-type="doi">10.1093/clinchem/18.6.499</pub-id>
<pub-id pub-id-type="pmid">4337382</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0014"><string-name><surname>Sattar</surname><given-names>A</given-names></string-name>, <string-name><surname>Weissfeld</surname><given-names>LA</given-names></string-name>, <string-name><surname>Molenberghs</surname><given-names>G</given-names></string-name>. <article-title>Analysis of non‐ignorable missing and left‐censored longitudinal data using a weighted random effects tobit model</article-title>. <source>Stat Med.</source><year>2011</year>;<volume>30</volume>:<fpage>3167</fpage>–<lpage>3180</lpage>. doi: <pub-id pub-id-type="doi">10.1002/sim.4344</pub-id>
<pub-id pub-id-type="pmid">21898524</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0015"><string-name><surname>Kovell</surname><given-names>LC</given-names></string-name>, <string-name><surname>Yeung</surname><given-names>EH</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Christenson</surname><given-names>RH</given-names></string-name>, <string-name><surname>Rebuck</surname><given-names>H</given-names></string-name>, <string-name><surname>Schulman</surname><given-names>SP</given-names></string-name>, <string-name><surname>Juraschek</surname><given-names>SP</given-names></string-name>. <article-title>Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: results from the OmniHeart trial</article-title>. <source>Int J Cardiol.</source><year>2020</year>;<volume>299</volume>:<fpage>282</fpage>–<lpage>288</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijcard.2019.07.102</pub-id>
<pub-id pub-id-type="pmid">31447226</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0016"><string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Carey</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Swain</surname><given-names>JF</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Conlin</surname><given-names>PR</given-names></string-name>, <string-name><surname>Erlinger</surname><given-names>TP</given-names></string-name>, <string-name><surname>Rosner</surname><given-names>BA</given-names></string-name>, <string-name><surname>Laranjo</surname><given-names>NM</given-names></string-name>, et al. <article-title>Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial</article-title>. <source>JAMA.</source><year>2005</year>;<volume>294</volume>:<fpage>2455</fpage>–<lpage>2464</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.294.19.2455</pub-id>
<pub-id pub-id-type="pmid">16287956</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0017"><string-name><surname>Jia</surname><given-names>X</given-names></string-name>, <string-name><surname>Sun</surname><given-names>W</given-names></string-name>, <string-name><surname>Hoogeveen</surname><given-names>RC</given-names></string-name>, <string-name><surname>Nambi</surname><given-names>V</given-names></string-name>, <string-name><surname>Matsushita</surname><given-names>K</given-names></string-name>, <string-name><surname>Folsom</surname><given-names>AR</given-names></string-name>, <string-name><surname>Heiss</surname><given-names>G</given-names></string-name>, <string-name><surname>Couper</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>SD</given-names></string-name>, <string-name><surname>Boerwinkle</surname><given-names>E</given-names></string-name>, et al. <article-title>High‐sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study</article-title>. <source>Circulation.</source><year>2019</year>;<volume>139</volume>:<fpage>2642</fpage>–<lpage>2653</lpage>. doi: <pub-id pub-id-type="doi">10.1161/circulationaha.118.038772</pub-id>
<pub-id pub-id-type="pmid">31030544</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0018"><string-name><surname>Samman Tahhan</surname><given-names>A</given-names></string-name>, <string-name><surname>Sandesara</surname><given-names>P</given-names></string-name>, <string-name><surname>Hayek</surname><given-names>SS</given-names></string-name>, <string-name><surname>Hammadah</surname><given-names>M</given-names></string-name>, <string-name><surname>Alkhoder</surname><given-names>A</given-names></string-name>, <string-name><surname>Kelli</surname><given-names>HM</given-names></string-name>, <string-name><surname>Topel</surname><given-names>M</given-names></string-name>, <string-name><surname>O'Neal</surname><given-names>WT</given-names></string-name>, <string-name><surname>Ghasemzadeh</surname><given-names>N</given-names></string-name>, <string-name><surname>Ko</surname><given-names>YA</given-names></string-name>, et al. <article-title>High‐sensitivity troponin I levels and coronary artery disease severity, progression, and long‐term outcomes</article-title>. <source>J Am Heart Assoc.</source><year>2018</year>;<volume>7</volume>:<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.1161/jaha.117.007914</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0019"><string-name><surname>McEvoy</surname><given-names>JW</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ndumele</surname><given-names>CE</given-names></string-name>, <string-name><surname>Solomon</surname><given-names>SD</given-names></string-name>, <string-name><surname>Nambi</surname><given-names>V</given-names></string-name>, <string-name><surname>Ballantyne</surname><given-names>CM</given-names></string-name>, <string-name><surname>Blumenthal</surname><given-names>RS</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>, <string-name><surname>Selvin</surname><given-names>E</given-names></string-name>. <article-title>Six‐year change in high‐sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death</article-title>. <source>JAMA Cardiol.</source><year>2016</year>;<volume>1</volume>:<fpage>519</fpage>–<lpage>528</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamacardio.2016.0765</pub-id>
<pub-id pub-id-type="pmid">27439107</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0020"><string-name><surname>Juraschek</surname><given-names>SP</given-names></string-name>, <string-name><surname>Woodward</surname><given-names>M</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Carey</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>. <article-title>Time course of change in blood pressure from sodium reduction and the DASH diet</article-title>. <source>Hypertension.</source><year>2017</year>;<volume>70</volume>:<fpage>923</fpage>–<lpage>929</lpage>. doi: <pub-id pub-id-type="doi">10.1161/hypertensionaha.117.10017</pub-id>
<pub-id pub-id-type="pmid">28993451</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0021"><string-name><surname>Libby</surname><given-names>P</given-names></string-name>, <string-name><surname>Ridker</surname><given-names>PM</given-names></string-name>, <string-name><surname>Hansson</surname><given-names>GK</given-names></string-name>. <article-title>Inflammation in atherosclerosis: from pathophysiology to practice</article-title>. <source>J Am Coll Cardiol.</source><year>2009</year>;<volume>54</volume>:<fpage>2129</fpage>–<lpage>2138</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2009.09.009</pub-id>
<pub-id pub-id-type="pmid">19942084</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0022"><string-name><surname>Wang</surname><given-names>A</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>C</given-names></string-name>, <string-name><surname>Gao</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S</given-names></string-name>, <string-name><surname>Wu</surname><given-names>S</given-names></string-name>, <string-name><surname>Ding</surname><given-names>H</given-names></string-name>, <string-name><surname>Fan</surname><given-names>H</given-names></string-name>, <string-name><surname>Hou</surname><given-names>S</given-names></string-name>. <article-title>Cumulative exposure to high‐sensitivity C‐reactive protein predicts the risk of cardiovascular disease</article-title>. <source>J Am Heart Assoc.</source><year>2017</year>;<volume>6</volume>:<fpage>6</fpage>. doi: <pub-id pub-id-type="doi">10.1161/jaha.117.005610</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0023"><string-name><surname>Soltani</surname><given-names>S</given-names></string-name>, <string-name><surname>Chitsazi</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Salehi‐Abargouei</surname><given-names>A</given-names></string-name>. <article-title>The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: A systematic review and meta‐analysis of randomized trials</article-title>. <source>Clin Nutr.</source><year>2018</year>;<volume>37</volume>:<fpage>542</fpage>–<lpage>550</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2017.02.018</pub-id>
<pub-id pub-id-type="pmid">28302405</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0024"><string-name><surname>Chiavaroli</surname><given-names>L</given-names></string-name>, <string-name><surname>Viguiliouk</surname><given-names>E</given-names></string-name>, <string-name><surname>Nishi</surname><given-names>SK</given-names></string-name>, <string-name><surname>Blanco Mejia</surname><given-names>S</given-names></string-name>, <string-name><surname>Rahelić</surname><given-names>D</given-names></string-name>, <string-name><surname>Kahleová</surname><given-names>H</given-names></string-name>, <string-name><surname>Salas‐Salvadó</surname><given-names>J</given-names></string-name>, <string-name><surname>Kendall</surname><given-names>CW</given-names></string-name>, <string-name><surname>Sievenpiper</surname><given-names>JL</given-names></string-name>. <article-title>DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta‐analyses</article-title>. <source>Nutrients.</source><year>2019</year>;<volume>11</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu11020338</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0025"><string-name><surname>Kavsak</surname><given-names>PA</given-names></string-name>, <string-name><surname>Worster</surname><given-names>A</given-names></string-name>, <string-name><surname>Hill</surname><given-names>SA</given-names></string-name>, <string-name><surname>Jaffe</surname><given-names>AS</given-names></string-name>. <article-title>Evaluation of the Siemens ADVIA centaur high‐sensitivity cardiac troponin I assay in serum</article-title>. <source>Clin Chim Acta.</source><year>2018</year>;<volume>487</volume>:<fpage>216</fpage>–<lpage>221</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cca.2018.10.012</pub-id>
<pub-id pub-id-type="pmid">30296440</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0026"><string-name><surname>Doumatey</surname><given-names>AP</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>J</given-names></string-name>, <string-name><surname>Adeyemo</surname><given-names>A</given-names></string-name>, <string-name><surname>Rotimi</surname><given-names>C</given-names></string-name>. <article-title>High sensitivity C‐reactive protein (Hs‐CRP) remains highly stable in long‐term archived human serum</article-title>. <source>Clin Biochem.</source><year>2014</year>;<volume>47</volume>:<fpage>315</fpage>–<lpage>318</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2013.12.014</pub-id>
<pub-id pub-id-type="pmid">24373927</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0027"><string-name><surname>Mueller</surname><given-names>T</given-names></string-name>, <string-name><surname>Gegenhuber</surname><given-names>A</given-names></string-name>, <string-name><surname>Dieplinger</surname><given-names>B</given-names></string-name>, <string-name><surname>Poelz</surname><given-names>W</given-names></string-name>, <string-name><surname>Haltmayer</surname><given-names>M</given-names></string-name>. <article-title>Long‐term stability of endogenous B‐type natriuretic peptide (BNP) and amino terminal proBNP (NT‐proBNP) in frozen plasma samples</article-title>. <source>Clin Chem Lab Med.</source><year>2004</year>;<volume>42</volume>:<fpage>942</fpage>–<lpage>944</lpage>. doi: <pub-id pub-id-type="doi">10.1515/cclm.2004.153</pub-id>
<pub-id pub-id-type="pmid">15387447</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0028"><string-name><surname>Heidenreich</surname><given-names>PA</given-names></string-name>, <string-name><surname>Bozkurt</surname><given-names>B</given-names></string-name>, <string-name><surname>Aguilar</surname><given-names>D</given-names></string-name>, <string-name><surname>Allen</surname><given-names>LA</given-names></string-name>, <string-name><surname>Byun</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Colvin</surname><given-names>MM</given-names></string-name>, <string-name><surname>Deswal</surname><given-names>A</given-names></string-name>, <string-name><surname>Drazner</surname><given-names>MH</given-names></string-name>, <string-name><surname>Dunlay</surname><given-names>SM</given-names></string-name>, <string-name><surname>Evers</surname><given-names>LR</given-names></string-name>, et al. <article-title>2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines</article-title>. <source>Circulation.</source><year>2022</year>;<volume>145</volume>:<fpage>e876</fpage>–<lpage>e894</lpage>. doi: <pub-id pub-id-type="doi">10.1161/cir.0000000000001062</pub-id>
<pub-id pub-id-type="pmid">35363500</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0029"><string-name><surname>Clerico</surname><given-names>A</given-names></string-name>, <string-name><surname>Passino</surname><given-names>C</given-names></string-name>, <string-name><surname>Franzini</surname><given-names>M</given-names></string-name>, <string-name><surname>Emdin</surname><given-names>M</given-names></string-name>. <article-title>Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides</article-title>. <source>Clin Chim Acta.</source><year>2015</year>;<volume>443</volume>:<fpage>17</fpage>–<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cca.2014.06.003</pub-id>
<pub-id pub-id-type="pmid">24937843</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0030"><string-name><surname>Clerico</surname><given-names>A</given-names></string-name>, <string-name><surname>Zaninotto</surname><given-names>M</given-names></string-name>, <string-name><surname>Padoan</surname><given-names>A</given-names></string-name>, <string-name><surname>Ndreu</surname><given-names>R</given-names></string-name>, <string-name><surname>Musetti</surname><given-names>V</given-names></string-name>, <string-name><surname>Masotti</surname><given-names>S</given-names></string-name>, <string-name><surname>Prontera</surname><given-names>C</given-names></string-name>, <string-name><surname>Passino</surname><given-names>C</given-names></string-name>, <string-name><surname>Carlo Zucchelli</surname><given-names>G</given-names></string-name>, <string-name><surname>Plebani</surname><given-names>M</given-names></string-name>, et al. <article-title>Harmonization of two hs‐cTnI methods based on recalibration of measured quality control and clinical samples</article-title>. <source>Clin Chim Acta.</source><year>2020</year>;<volume>510</volume>:<fpage>150</fpage>–<lpage>156</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cca.2020.07.009</pub-id>
<pub-id pub-id-type="pmid">32652160</pub-id></mixed-citation>
              </ref>
              <ref id="jah38102-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jah38102-cit-0031"><string-name><surname>Clerico</surname><given-names>A</given-names></string-name>, <string-name><surname>Ripoli</surname><given-names>A</given-names></string-name>, <string-name><surname>Zaninotto</surname><given-names>M</given-names></string-name>, <string-name><surname>Masotti</surname><given-names>S</given-names></string-name>, <string-name><surname>Musetti</surname><given-names>V</given-names></string-name>, <string-name><surname>Ciaccio</surname><given-names>M</given-names></string-name>, <string-name><surname>Aloe</surname><given-names>R</given-names></string-name>, <string-name><surname>Rizzardi</surname><given-names>S</given-names></string-name>, <string-name><surname>Dittadi</surname><given-names>R</given-names></string-name>, <string-name><surname>Carrozza</surname><given-names>C</given-names></string-name>, et al. <article-title>Head‐to‐head comparison of plasma cTnI concentration values measured with three high‐sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi‐center study</article-title>. <source>Clin Chim Acta.</source><year>2019</year>;<volume>496</volume>:<fpage>25</fpage>–<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cca.2019.06.012</pub-id>
<pub-id pub-id-type="pmid">31201817</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
